StockData
DMIINasdaqBlank ChecksFiscal year ends December 31Also trades as DMIIR, DMIIU

Drugs Made In America Acquisition II Corp.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$10.18−0.00 (-0.05%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

SEC filings

12 of Drugs Made In America Acquisition II's most recent filings on SEC EDGAR

DocumentFormPeriodFiledSource
Quarterly report10-QJun 30, 2026Aug 14, 2026SEC EDGAR
Quarterly report10-QMar 31, 2026May 14, 2026SEC EDGAR
Current report8-KApr 22, 2026Apr 28, 2026SEC EDGAR
Annual report10-KDec 31, 2025Apr 15, 2026SEC EDGAR
Current report8-KMar 24, 2026Apr 3, 2026SEC EDGAR
Current report8-KMar 11, 2026Mar 17, 2026SEC EDGAR
Current report8-KMar 6, 2026Mar 6, 2026SEC EDGAR
Current report8-KFeb 28, 2026Mar 6, 2026SEC EDGAR
Quarterly report10-QSep 30, 2025Nov 18, 2025SEC EDGAR
Current report8-KOct 8, 2025Nov 18, 2025SEC EDGAR
Current report8-KSep 26, 2025Oct 2, 2025SEC EDGAR
Current report8-KSep 24, 2025Sep 29, 2025SEC EDGAR